Scientists Discover Alzheimer’s Trigger with Drug Potential in Mice

Dementia affects millions globally and remains hard to treat. Scientists have found a potential new target for future treatments. They slowed dementia in mice using this discovery.

The target is an enzyme called G protein-coupled receptor kinase 2 (GRK2), important for cell health. GRK2 helps cells handle stress. Researchers found a faulty version of GRK2 that may relate to dementia.

This inactive GRK2 gathers around mitochondria, which are vital cell parts often linked to Alzheimer’s disease. A team at ETH Zurich in Switzerland studied the connection between GRK2 and dementia.

They found a lot of inactive GRK2 in the brain cells of both mice and humans with Alzheimer’s. In mice, it also increased amyloid-beta protein, associated with this disease.

Inactive GRK2 builds up like amyloid beta and harms mitochondria, causing stress in brain cells. This creates a harmful cycle, worsening the problem.

The researchers developed a compound called Compound 10. It stops inactive GRK2 from clumping, helping mitochondria work better and reducing amyloid beta. In mice, this slowed dementia’s progress.

While more research is needed, including on human samples, results are promising. GRK2 was not deeply studied in Alzheimer’s before. Researchers say GRK2 could offer new ways to address the complex disease. The study was published in Cell Reports Medicine.

How much do you know?

What enzyme is identified as a potential target for dementia treatment?

GRK1

GRK2

GRK3

GRK4

Which institution conducted the study on GRK2 and dementia?

Harvard University

ETH Zurich

Stanford University

Oxford University

What is the function of GRK2 in cells?

To promote cell division

To handle stress

To enhance cell motility

To regulate cell death

What compound did researchers develop to help with GRK2 inactivity?

Compound 1

Compound 5

Compound 10

Compound 20

What harmful protein is associated with Alzheimer's disease that increased in mice?

Tau protein

Neurofibrillary tangles

Amyloid-beta

Cerebral amyloid angiopathy

Is more research needed on human samples regarding GRK2's effects on dementia?

Yes

No

Inactive GRK2 has a beneficial effect on mitochondria.

True False

The study on GRK2 and dementia was published in Cell Reports Medicine.

True False

GRK2 is known to promote Alzheimer’s disease.

True False

The researchers found an active version of GRK2 in the brain cells of Alzheimer’s patients.

True False

Compound 10 assists in preventing inactive GRK2 from clumping.

True False

Dementia only affects a small number of individuals globally.

True False

Dementia affects millions globally and remains hard to treat. Scientists have found a potential new target for future treatments, specifically an enzyme called GRK2, which is important for cell health. GRK2 helps cells handle .

Inactive GRK2 gathers around mitochondria, which are vital cell parts often linked to disease.

In the brain cells of mice and humans with Alzheimer's, researchers found a lot of GRK2.

Inactive GRK2 builds up like amyloid beta and harms mitochondria, causing stress in brain .

The researchers developed a compound called Compound 10, which stops inactive GRK2 from clumping and helps work better.

While more research is needed, including on human samples, results from the study were very .

This question is required